It has been demonstrated that BIIB021 can promote apoptosis in imatinib-resistant CML cells by inducing autophagy through the Akt-mTOR-ULK1 pathway (He et al., 2016). This evidence concerns the gene ULK1 and chronic myelogenous leukemia, BCR-ABL1 positive.